activity is significantly associated with the expression of one of the lncRNA CARLo-5. MYC enhancer region that physically interacts with the active regulatory region of the CARLo-5 promoter, suggesting long-range interaction of MYC enhancer with the CARLo-5 promoter regulates CARLo-5 expression. 14 Taking into account previous studies, it is also possible that other genetic variants found in these CARLos may influence the expression of MYC. Many studies in Pakistan have stated the association of SNPs and environmental risks with bladder cancer (BC), but to the best of our knowledge, association or impact of lncRNA with MYC gene has not yet been reported. To address this, the current study focussed on the possible role of lncRNA with MYC. The aim was to determine the impact of CARLos on proto-oncogene MYC expression. We also found that only CARLo-7 is expressed in bladder tissue from the entire cluster of CARLos. We also found that CARLo-7 harbours the bladder cancer-associated SNP rs9642880. Interestingly, we found that MYC does not serve as a sole determinant for bladder cancer metastasis. We did not find any correlation between the expression of CARLo-7 and MYC. Our result indicates that CARLo-7 has a bladder cancer-specific function as its expression varies according to tumour grade.
| MATERIALS AND METHODS

| Tumour sampling
Seven paired tumour and normal tissue samples and fourteen unpaired tumour samples were collected from postsurgical bladder cancer patients. Tissues were taken regardless of gender, age, geographical region and stage specificity. Histopathological reports of the patients were taken from the hospitals (Armed Forces Institute of Urology, Rawalpindi, and Shifa International Hospital, Islamabad, Pakistan) were used. Tumour samples were classified as high grade and low grade. Before tissue collection, an informed written consent was signed from each patient. Post-surgical tumour samples of about > 5 mm size, weighing approximately 100-150 mg, were collected. Microscopically examined surrounding healthy tissue (2 cm away from tumour growth) was taken as positive control.
| Ethical approval
The study was approved by the ethical review board (ERB) of COMSATS Institute of Information Technology, Islamabad (No. CIIT/Bio/ERB/18/76) and was conducted in accordance with the Helsinki declaration. ). The experiment was run for three biological replicates with negative controls each. The melt curve for each sample was performed to check for the non-targeted fragment amplification. The relative fold increase in the expression of the CARLo-7 and MYC genes was analysed using 2 −∆∆ C T method. 18 The data were normalized with the internal control used as TUB1, and average fold increase was determined by calculating the relative expressions of each tumour sample.
| Quantitative PCR
| Statistical analysis
Statistical analyses were performed with OriginPro 2017 (OriginLab, Northampton, MA). For expression data, CT values of the target genes CARLo-7 and MYC were normalized with the control gene (TUB1) CT. The statistical significance was determined using Mann-Whitney test.
| RESULTS
| Tumour grade and stage
Out of 21 bladder tumour samples, 12 were low grade and 9 were high grade according to the WHO/ISUP classification system. 19, 20 The histopathology reports of the patients were taken from the hospitals (Armed force Institute of Urology, Rawalpindi, and Shifa International Hospital, Islamabad, Pakistan), and according to the histopathology examination, the tumours that have been found having recurrent behaviour were categorized as high-grade tumours. There were 9 high-grade tumours that metastasized to the pelvic wall and prostate gland. In the lowgrade tumours, there were 12 tumours that had spread only to the subepithelial connective tissue of the bladder. The staging of the tumours was based on the TNM staging system (Table 1) .
| Expression of CarLo-7 is high in bladder tissue
The 8q24 locus bears susceptibility loci for prostate, breast, bladder, and lung cancers. 10 The 8q24.21 region is a regulatory region with different lncRNAs surrounding MYC. In the current study, we focused on a family of lncRNAs called CARLos, comprising 7 members hence CARLo1-7. The MYC gene has two lncRNAs (lncRNA) PVT1 and CARLo-7 (CASC11) in its vicinity. In bladder cancer knockdown of PVT1 induces apoptosis in bladder cancer cells, indicating its oncogenic potential. 21 Meta-analysis has shown the association of T allele from single nucleotide polymorphism (SNP) rs9642880 with bladder cancer. 22 Moreover, CARLo-7 also bears this SNP rs9642880 in the intron.rs942880 T allele and this is associated with high MYC expression at both RNA and protein levels in bladder cancer tissues. 23 CARLO-7 is ~2.1-kb upstream of the MYC proto-oncogene. The expression of CARLo-7 was high in bladder and prostate as opposed to whole blood, liver and lung ( Figure 1A ).
| CARLo-7 expression correlates with bladder cancer patients
We further investigated the role of CARLo-7 in bladder cancer. Interestingly, CARLo-7 transcript variants 1 and 2 also showed no amplification. However, CARLo-7 transcript variant 3 was amplified in both normal and cancerous bladder tissues, indicating the expression of CARLo-7 transcript variant 3 in the samples. CARLo-7 expression varies with the tumour grade. The low-grade bladder cancer shows approximately fivefold decline in CARLo-7 expression as opposed to normal ( Figure 1B ). Moreover, we observed decrease in expression of CARLo-7 in female low-grade bladder cancer patients as opposed to male patients ( Figure 1C) . Interestingly, we observed a significant increase in CARLo-7 expression at the muscle-invasive T2NoMo stage of bladder cancer. Since there was only one female in the high-grade bladder cancer cases, therefore we have not analysed the genderwise difference in expression of CARLo-7. The high-grade tumour samples showed a significant threefold increase as compared to normal ( Figure 1B ). Similar to low-grade bladder cancer, the metastatic stage T2N2M2 showed a significant increase as opposed to the papillary stage ( Figure 1E ). This depicts a direct relationship between CARLo-7 expression and tumour progression. High-grade tumours are aggressive and tend to metastasize quickly. This result indicates the potential role of CARLo-7 in bladder cancer metastasis. However, although the precise mechanism behind this trend still needs to be determined, we can hypothesize that CARLo-7 may be the regulator of cell proliferation. Its expression increases with cell proliferation leading to tumour metastasis. Since there were 7 different CARLos, we also checked the expression of CARLo-1, CARLo-2, CARLo-3, CARLo-4 and CARLo-6. None of these were amplified. Therefore, the expression of isoform 3 of CARLO-7 is bladder tissue specific.
Interestingly, we observed amplification of CARLo-5 in a high-grade papillary urothelial carcinoma. Due to the unavailability of adequate sample size of high-grade papillary urothelial carcinoma, we were unable to further correlate CARLo-5 with bladder cancer.
| MYC expression and bladder cancer
The presence of rs9642880 SNP in CARLO-7 intron further intrigued us to check the expression of MYC. We assumed that the expression of CARLO-7 might affect MYC expression or vice versa. We observed approximately fourfold increase in MYC expression in low-grade tumour, and high-grade tumour showed 5.5-fold increase compared to normal (Figure 2A) . Moreover, stagewise and genderwise expression of MYC in both low-and high-grade cancer showed no significant difference at RNA level (Figure 2B-D) . However, this trend of MYC expression does not correlate with the CARLO-7 expression. The 1.5-fold difference in MYC expression between low-grade and high-grade tumours indicates that MYC might not be the sole determinant of tumour progression. This observation is in line with the previous finding. 24 This result shows that the increased expression of MYC might be responsible for initiation of cell proliferation, but there might be other factors modulating the tumour progression.
The expression correlation of linc00990 and MYC in high-grade bladder cancer raised the possibility of MYCbinding sites in the upstream region of linc00990. We further investigated whether MYC being a transcription factor might regulate linc00990. MYC being a heterodimeric basic helix loop helix and leucine zipper (bHLHZip) transcription factor, it interacts with other bHLHZip proteins like MAX to form a transcription-competent complex. 25 We found two 
| DISCUSSION
The 8q24 primarily thought as a gene desert region is a regulatory hub comprising of several lncRNAs and the protooncogene MYC. Genomewide association studies have identified many cancers risk loci in this region. 26 Some of these lncRNAs like CCAT1 are located in the super-enhancer region and tend to regulate MYC expression. 27 Another cancer-specific lncRNA PCAT1 located on 8q24 regulates proliferation of prostate cancer cells via MYC. 28 In the present study, we observed elevated expression of linc00990 in high-grade bladder cancer. Linc00990 (CASC11) has been demonstrated as a regulator of cell proliferation and tumour metastasis in colorectal cancer by activating Wnt/β-catenin signalling pathway. 29 The high expression of linc00990 in the invasive and aggressive high-grade bladder cancer reflected its potential to promote tumour invasiveness. Moreover, the T allele of linc00990 intronic SNP rs9642880 is associated with higher MYC expression at both RNA and protein levels. 22, 23 MYC encodes c-MYC, an oncogenic transcription factor regulating expression of several protein and non-coding RNAs. 25 MYC binds selectively and rapidly to its target sequence CACGTG (Enhancer box (E-box)). Previous ChipChip data revealed strong dependency of MYC binding on the presence of H3K4me3 mark in the promoter region regardless of its binding sequence preference. 30 in low-grade bladder cancer indicated that MYC might not be regulating linc00990 or a sufficient amount of MYC protein is required to increase linc00990 expression. The slight increase of 1.5-fold of MYC in high-grade as compared to lowgrade tumour indicates that it might not be determining the metastatic potential in case of bladder cancer. Previous studies have also shown that MYC does not play a critical role in determining bladder cancer stage or grade. 32 However, the significant increase of MYC expression in tumour cases as opposed to normal indicates that MYC might be necessary for cell cycle competence. Our results lead us to conclusion that transcript variant 3 of Linc00990 might be involved in conferring susceptibility to urinary bladder cancer in Pakistani population. Linc00990 (transcript variant-3) can serve as a new prognostic marker for bladder cancer metastasis.
